These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29107620)

  • 21. Ecological fallacy as a novel risk factor for poor translation in neuroscience research: A systematic review and simulation study.
    Cragg JJ; Kramer JLK; Borisoff JF; Patrick DM; Ramer MS
    Eur J Clin Invest; 2019 Feb; 49(2):e13045. PubMed ID: 30372787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevating standards for discoveries reported in ACS Chemical Neuroscience: new criteria to enhance reproducibility, experimental transparency, reliability, and the value of negative data.
    Lindsley CW
    ACS Chem Neurosci; 2014 Oct; 5(10):868-9. PubMed ID: 25315492
    [No Abstract]   [Full Text] [Related]  

  • 23. Introduction to the special issue on circadian rhythms in behavioral neuroscience.
    Weil ZM; Nelson RJ
    Behav Neurosci; 2014 Jun; 128(3):237-9. PubMed ID: 24886186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanotechnology in Neuroscience and its Perspective as Gene Carrier.
    Khanh TMT; Wei D; Tran PHL; Tran TTD
    Curr Top Med Chem; 2017; 17(12):1379-1389. PubMed ID: 28017150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethical and social aspects of genetics and neuroscience: the Wellcome proposals.
    Alderson P
    Bull Med Ethics; 1998 Mar; No. 136():20-1. PubMed ID: 11657530
    [No Abstract]   [Full Text] [Related]  

  • 26. The significance of meaning: why do over 90% of behavioral neuroscience results fail to translate to humans, and what can we do to fix it?
    Garner JP
    ILAR J; 2014; 55(3):438-56. PubMed ID: 25541546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective drug delivery approaches to lesioned brain through blood brain barrier disruption.
    Al-Ahmady ZS
    Expert Opin Drug Deliv; 2018 Apr; 15(4):335-349. PubMed ID: 29466890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proceedings of the 2013 CINP summit: innovative partnerships to accelerate CNS drug discovery for improved patient care.
    Phillips AG; Hongaard-Andersen P; Moscicki RA; Sahakian B; Quirion R; Krishnan KR; Race T
    Int J Neuropsychopharmacol; 2014 Dec; 18(3):. PubMed ID: 25542690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three requirements for justifying an educational neuroscience.
    Hruby GG
    Br J Educ Psychol; 2012 Mar; 82(Pt 1):1-23. PubMed ID: 22429055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introduction to the special issue from the 2014 meeting of the International Behavioral Neuroscience Society.
    Young JW; Hall FS; Pletnikov M; Kent S
    Neurosci Biobehav Rev; 2015 Nov; 58():1-3. PubMed ID: 26672720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rethinking Giftedness and Gifted Education: A Proposed Direction Forward Based on Psychological Science.
    Subotnik RF; Olszewski-Kubilius P; Worrell FC
    Psychol Sci Public Interest; 2011 Jan; 12(1):3-54. PubMed ID: 26168418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept.
    Reichel A
    Chem Biodivers; 2009 Nov; 6(11):2030-49. PubMed ID: 19937839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroscience in Nigeria: the past, the present and the future.
    Balogun WG; Cobham AE; Amin A
    Metab Brain Dis; 2018 Apr; 33(2):359-368. PubMed ID: 28993966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Financial anatomy of neuroscience research.
    Dorsey ER; Vitticore P; De Roulet J; Thompson JP; Carrasco M; Johnston SC; Holloway RG; Moses H
    Ann Neurol; 2006 Dec; 60(6):652-9. PubMed ID: 17192926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translational aspects of blood-brain barrier transport and central nervous system effects of drugs: from discovery to patients.
    de Lange EC; Hammarlund-Udenaes M
    Clin Pharmacol Ther; 2015 Apr; 97(4):380-94. PubMed ID: 25670219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The blood-brain barrier: bottleneck in brain drug development.
    Pardridge WM
    NeuroRx; 2005 Jan; 2(1):3-14. PubMed ID: 15717053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomedical research and the commercialization agenda: a review of main considerations for neuroscience.
    Caulfield T; Ogbogu U
    Account Res; 2008; 15(4):303-20. PubMed ID: 18972268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Teensy microcontroller-based interface for optical imaging camera control during behavioral experiments.
    Romano M; Bucklin M; Gritton H; Mehrotra D; Kessel R; Han X
    J Neurosci Methods; 2019 May; 320():107-115. PubMed ID: 30946877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A commitment and vision to the future of the Journal of Neuroscience Research.
    Prager EM
    J Neurosci Res; 2016 Dec; 94(12):1373. PubMed ID: 27662078
    [No Abstract]   [Full Text] [Related]  

  • 40. The 9 to 5 Rodent - Time for Change? Scientific and animal welfare implications of circadian and light effects on laboratory mice and rats.
    Hawkins P; Golledge HDR
    J Neurosci Methods; 2018 Apr; 300():20-25. PubMed ID: 28502554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.